SCHEMBL9698980

SCHEMBL9698980

CN(CCN(CCC(=O)O)C(=O)OCc1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.53
PAX8 Q06710 1/20 0.53
F13A1 P00488 1/20 0.48
TGM2 P21980 1/20 0.48
TGM1 P22735 1/20 0.48
HTT P42858 1/20 0.46
HDAC1 Q13547 1/20 0.45
ALDH1A1 P00352 4/20 0.45
FOLH1 Q04609 2/20 0.43
ABCB1 P08183 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LTA4H P09960 1/20 0.40
PRSS1 P07477 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL164180 0.90 ALDH1A1 (0.51) CCR6PAX8F13A1TGM2TGM1
SCHEMBL31629174 0.90 CCR6 (0.62) CCR6PAX8HTTHDAC1ALDH1A1
SCHEMBL7367495 0.87 ALDH1A1 (0.58) CCR6PAX8F13A1TGM2TGM1
SCHEMBL9699043 0.85 CCR6 (0.59) CCR6PAX8F13A1TGM2TGM1
SCHEMBL3968828 0.84 CCR6 (0.54) CCR6PAX8HTTALDH1A1ABCB1
SCHEMBL7366351 0.84 CCR6 (0.53) CCR6PAX8HTTALDH1A1MAPK1
SCHEMBL393422 0.84 HTT (0.52) CCR6PAX8F13A1TGM2TGM1
SCHEMBL2212416 0.84 CCR6 (0.57) CCR6PAX8HTTHDAC1ALDH1A1
SCHEMBL23683127 0.83 CCR6 (0.56) CCR6PAX8HTTHDAC1ALDH1A1
SCHEMBL389007 0.83 HTT (0.51) CCR6PAX8F13A1TGM2TGM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992002521-A1 1-AZABICYCLO[3.2.0]HEPT-2-ENE-2-CARBOXYLIC ACID COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-20 WO disclosed